Analyst · Arcadia Biosciences, Inc. (RKDA) | Ratings, Price Targets & Consensus

Analyst Consensus

Buy0 analysts

Buy

Updated Aug 23, 2026

Total Analysts0

Buy

4

Hold

1

Ratings

Updated Aug 23, 2026

Overall Rating

D+

DCF Score1.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.46

Median Target-100.00%

$0.00

Potential downside vs current price

Current Stock Price

$0.46

Median Target-100.00%

$0.00

Potential downside vs current price

Analyst Consensus

Buy0 analysts

Buy

Updated Aug 23, 2026

Total Analysts0

Buy

4

Hold

1

Ratings

Updated Aug 23, 2026

Overall Rating

D+

DCF Score1.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.46

Median Target-100.00%

$0.00

Potential downside vs current price

Current Stock Price

$0.46

Median Target-100.00%

$0.00

Potential downside vs current price